Lisanti Capital Growth, LLC Portfolio Holdings

Lisanti Capital Growth, LLC

  • $297 Million
  • Q1 2025

Lisanti Capital Growth, LLC has filed its 13F form on April 24, 2025 for Q1 2025 where it was disclosed a total value porftolio of $297 Million distributed in 108 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $11.4M, Palomar Holdings, Inc. with a value of $7.93M, Ani Pharmaceuticals Inc with a value of $7.06M, Casella Waste Systems Inc with a value of $6.98M, and Kratos Defense & Security Solutions, Inc. with a value of $6.46M.

Examining the 13F form we can see an decrease of $74.1M in the current position value, from $371M to 297M.

Below you can find more details about Lisanti Capital Growth, LLC portfolio as well as his latest detailed transactions.

Portfolio value $297 Million
Healthcare: $83.3 Million
Technology: $62.1 Million
Industrials: $58.6 Million
Consumer Cyclical: $30 Million
Financial Services: $23.7 Million
Consumer Defensive: $20.6 Million
Communication Services: $12 Million
Energy: $3.75 Million
Other: $3.34 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$7.53B
$2.69 Million 0.9% of portfolio
51,925
Q1 2025 New
$3.02B
$2.56 Million 0.86% of portfolio
59,455
Q1 2025 New
$1.6B
$2.57 Million 0.86% of portfolio
93,825
Q1 2025 New
$3.23B
$2.42 Million 0.81% of portfolio
49,800
Q1 2025 New
$574M
$2.36 Million 0.8% of portfolio
168,525
Q1 2025 New
$4.67B
$2.25 Million 0.76% of portfolio
9,590
Q1 2025 Reduced 52.43%
$1.31B
$2.19 Million 0.73% of portfolio
265,855
Q1 2025 New
$321M
$2.12 Million 0.71% of portfolio
252,215
Q1 2025 New
$13.8B
$2.09 Million 0.7% of portfolio
17,885
Q1 2025 Reduced 59.49%
$181M
$2.05 Million 0.69% of portfolio
411,675
Q1 2025 New
$6.85B
$1.99 Million 0.67% of portfolio
79,055
Q1 2025 New
$3.58B
$1.94 Million 0.65% of portfolio
28,870
Q1 2025 New
$6.81B
$1.9 Million 0.64% of portfolio
32,735
Q1 2025 New
$740M
$1.88 Million 0.63% of portfolio
215,555
Q1 2025 New
$4.45B
$1.81 Million 0.61% of portfolio
11,820
Q1 2025 Reduced 59.58%
$1.71B
$1.74 Million 0.59% of portfolio
39,015
Q1 2025 Added 53.42%
$13.9B
$1.6 Million 0.54% of portfolio
11,320
Q1 2025 Reduced 2.33%
$15.6B
$1.6 Million 0.54% of portfolio
4,745
Q1 2025 Reduced 2.37%
$14.6B
$1.56 Million 0.53% of portfolio
49,380
Q1 2025 Added 38.03%
$4.46B
$1.42 Million 0.48% of portfolio
18,975
Q1 2025 New
$1.88B
$1.39 Million 0.47% of portfolio
32,350
Q1 2025 Reduced 51.01%
$833M
$1.37 Million 0.46% of portfolio
76,835
Q1 2025 Reduced 12.74%
$6.2B
$1.37 Million 0.46% of portfolio
11,385
Q1 2025 New
$5.31B
$1.33 Million 0.45% of portfolio
7,710
Q1 2025 New
$4.83B
$1.34 Million 0.45% of portfolio
31,380
Q1 2025 New
$4.43B
$1.31 Million 0.44% of portfolio
17,910
Q1 2025 Reduced 2.34%
$2.77B
$1.29 Million 0.43% of portfolio
40,795
Q1 2025 New
$14.2B
$1.27 Million 0.43% of portfolio
11,160
Q1 2025 New
$1.57B
$1.25 Million 0.42% of portfolio
50,080
Q1 2025 Reduced 75.86%
$1.36B
$1.06 Million 0.36% of portfolio
41,545
Q1 2025 New
$8.72B
$1.07 Million 0.36% of portfolio
4,005
Q1 2025 New
$5.6B
$1.04 Million 0.35% of portfolio
53,850
Q1 2025 New
$18.6B
$928,000 0.31% of portfolio
2,925
Q1 2025 Reduced 49.0%
$12.6B
$874,000 0.29% of portfolio
14,465
Q1 2025 Added 162.05%
$2.72B
$832,000 0.28% of portfolio
61,400
Q1 2025 Reduced 79.52%
$5.07B
$821,000 0.28% of portfolio
10,700
Q1 2025 Reduced 78.95%
$4.39B
$793,000 0.27% of portfolio
11,875
Q1 2025 Reduced 15.21%
$3.68B
$766,000 0.26% of portfolio
4,810
Q1 2025 New
$2.51B
$757,000 0.25% of portfolio
12,275
Q1 2025 New
$17.2B
$558,000 0.19% of portfolio
8,005
Q1 2025 New
$29.9B
$466,000 0.16% of portfolio
3,425
Q1 2025 Reduced 2.28%
$29.2B
$425,000 0.14% of portfolio
2,035
Q1 2025 Reduced 52.95%
$13.6B
$243,000 0.08% of portfolio
6,070
Q1 2025 Reduced 92.27%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Lenz Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
$0
$0 0.0% of portfolio
193,830
Q1 2025 New
-
$0 0.0% of portfolio
-
Q1 2025 Added 26.85%
Nextracker Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Brightspring Health Svcs Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 3.35%

Summary

  • Portfolio
  • No. of Stocks 108
  • Current Value $297 Million
  • Prior Value $371 Million
  • Filing
  • Period Q1 2025
  • Filing Date April 24, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 55 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 32 stocks
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email